跳转到主要内容
搜索

早期临床

注册

最新资源

精选资源

Upcoming early clinical webinars

网络研讨会

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am – 10:30am APAC (JST): Thursday, November
网络研讨会

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

2025 年 12 月 2 日 – 11am EST - 12pm EST
网络研讨会

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

2025 年 12 月 9 日 – 10:00 am – 10:30 am, Korea time

Latest early clinical blogs

在以下活动中与我们的专家会面

All early clinical resources

From Insight to Impact: Certainty EMEA 2025

Certara Products, Certara Services, Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Certara Products - Certara IQ, Modeling and Simulation - QSP, Blog

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

网络研讨会

Using M&S to Evaluate Oncology Drug Dosing

Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Therapeutic Specialties, Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Certara Products, Certara Products - Certara IQ, Certara Products - Phoenix, Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Certara Products - Phoenix, Drug Development, Modeling and Simulation - PK/PD, Webinar

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pharmacometrics, Rare and Neglected Diseases, Therapeutic Specialties, Publication

Supporting KalVista’s NDA Submission for a Novel HAE Treatment​

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Case Study

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Certara Products - Certara IQ, Certara Services, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software